BLTE
BELITE BIO, INC
NASDAQ · Healthcare · Biotechnology · US
$152.85
+0.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 79.99x
- P/E 2028E
- 24.61x
- P/S forward
- 27.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.93x
- Price / sales
- —
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $6.2B
- EV / sales
- —
- EV / EBITDA
- -53.89x
- EV / EBIT
- -51.86x
- Market cap
- $6.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026